Search

Search Results for "Choroidal Neovascularization, CNV"

Variable Segmentation on Eyes With CNV with SPECTRALIS thumbnail

Variable Segmentation on Eyes With CNV with SPECTRALIS

Karl Csaky, MD, PhD; Steve Thomas, CRA

Part III: Photodynamic Therapy with VISUDYNE® thumbnail

Part III: Photodynamic Therapy with VISUDYNE^®

Gregg T. Kokame, MD, MMM, FASRS

Part I: Diagnosing AMD Patients With Predominantly Classic Neovascular Lesions Who Experience Persistent Retinal Fluid thumbnail

Part I: Diagnosing AMD Patients With Predominantly Classic Neovascular Lesions Who Experience Persistent Retinal Fluid

Gregg T. Kokame, MD, MMM, FASRS

Part II: Photodynamic Therapy With VISUDYNE® in Dr. Kokame’s Practice thumbnail

Part II: Photodynamic Therapy With VISUDYNE^® in Dr. Kokame’s Practice

Gregg T. Kokame, MD, MMM, FASRS

GA in the Presence of Dense Cataract, Followed by CNV Development thumbnail

GA in the Presence of Dense Cataract, Followed by CNV Development

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

Complement Inhibition Therapy in a Monocular Patient With a New CNV thumbnail

Complement Inhibition Therapy in a Monocular Patient With a New CNV

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

Thumbnail for nlgil

OCT-A for Identifying CNV in Patients with Type 1 AMD and Assessing Response to anti-VEGF treatment

David Boyer, MD

Thumbnail for nlgilx

OCT-A for the Detection of CNV in Types I, II, III and PCV CNV

Peter Kaiser, MD

Thumbnail for ivivi

OCT-A Shows Association Between Perforating Scleral Vessels and CNV in Pathologic Myopia

Francesco Bandello, MD

Thumbnail for manes

The Pathophysiology of Wet AMD

Genentech, Inc.

Evolving Practice Patterns and Dosing Strategies in Geographic Atrophy

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

View More